Wojtukiewicz M Z, Zacharski L R, Memoli V A, Kisiel W, Kudryk B J, Rousseau S M, Stump D C
Department of Medicine, Dartmouth Medical School, White River Junction, Vermont.
Am J Clin Pathol. 1990 Apr;93(4):516-21. doi: 10.1093/ajcp/93.4.516.
Immunohistochemical techniques applied to fresh frozen sections of metastatic malignant melanoma tissue revealed abundant fibrinogen (or fibrin I) in perivascular areas throughout the tumor connective tissue stroma. Fibrin was readily detected in a focal distribution in the connective tissue around nodules of viable tumor. Staining for D-dimer of cross-linked fibrin (using an antibody that cross-reacted with fragment D of fibrinogen) coincided with staining for fibrin. Diffuse staining of tumor cell bodies was observed for Factor X, and Factor XIII ("a" subunit) was detected in scattered areas of connective tissue throughout the tumors. Factor VII was not detected, and only rare tumor cells stained for tissue factor. These results support the concept that a tumor cell-associated, thrombin-generating pathway exists in situ in malignant melanoma tissue that includes Factor X but neither tissue factor nor Factor VII. By contrast, tumor cell staining was observed rarely for urokinase and to a variable extent for tissue plasminogen activator.
将免疫组织化学技术应用于转移性恶性黑色素瘤组织的新鲜冰冻切片,结果显示,在整个肿瘤结缔组织基质的血管周围区域存在大量纤维蛋白原(或纤维蛋白I)。在存活肿瘤结节周围的结缔组织中,纤维蛋白呈局灶性分布,易于检测。交联纤维蛋白D-二聚体染色(使用与纤维蛋白原D片段发生交叉反应的抗体)与纤维蛋白染色一致。肿瘤细胞体对因子X呈弥漫性染色,在整个肿瘤的结缔组织散在区域检测到因子 XIII(“a”亚基)。未检测到因子VII,仅极少数肿瘤细胞对组织因子染色。这些结果支持这样一种概念,即恶性黑色素瘤组织中存在一种与肿瘤细胞相关的凝血酶生成途径,该途径包含因子X,但不包含组织因子和因子VII。相比之下,很少观察到肿瘤细胞对尿激酶染色,对组织型纤溶酶原激活物的染色程度则各不相同。